Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science…
He is a Distinguished Researcher with Autodesk Inc. Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.
